Randomized phase II trial comparing IG-001 versus paclitaxel against first-line advanced ovarian cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.5590 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 5590-5590

Author(s):

Vuong N. Trieu ◽

Monica Choi ◽

Larn Hwang ◽

Osmond D'Cruz

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Randomized Phase Ii

Download Full-text

Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.194 ◽

2015 ◽

Vol 137 ◽

pp. 79

Author(s):

N.D. Fleming ◽

R.L. Coleman ◽

C.S. Tung ◽

M.F. Munsell ◽

A.K. Sood

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Phase II trial of oxaliplatin (OXA) combined with paclitaxel (P) as first-line chemotherapy for patients (pts) with advanced ovarian cancer (AOC): Preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.5075 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5075-5075

Author(s):

G. Deplanque ◽

A. Goupil ◽

M. Fabbro ◽

E. Levy ◽

O. Rixe ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Preliminary Results ◽

Line Chemotherapy

Download Full-text

Adjuvant chemotherapy of three steps (ACTS) in patients with newly diagnosed advanced ovarian cancer: interim analysis of a randomized phase II trial

Gynecologic Oncology ◽

10.1016/s0090-8258(21)00796-4 ◽

2021 ◽

Vol 162 ◽

pp. S82

Author(s):

Zhong Zheng ◽

Xiaohua Wu

Keyword(s):

Ovarian Cancer ◽

Adjuvant Chemotherapy ◽

Phase Ii ◽

Interim Analysis ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Newly Diagnosed ◽

Randomized Phase Ii

Download Full-text

Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB–IV

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.04.050 ◽

2012 ◽

Vol 126 (2) ◽

pp. 236-240 ◽

Author(s):

Werner Meier ◽

Andreas du Bois ◽

Jörn Rau ◽

Martina Gropp-Meier ◽

Klaus Baumann ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Cancer Stage ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717948618.793453724 ◽

2012 ◽

Author(s):

David Kushner ◽

Shitanshu Uppal

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Cancer Stage ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

Phase II trial of oxaliplatin (OXA) and topotecan (TOP) as a first line treatment for the patients (pts) with advanced ovarian cancer (AOC): Preliminary results of a pilot study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.5116 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5116-5116 ◽

Author(s):

V. Gorbounova ◽

S. Topchieva ◽

N. Besova

Keyword(s):

Ovarian Cancer ◽

Pilot Study ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Line Treatment ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

Phase II trial of bevacizumab with dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.07.137 ◽

2017 ◽

Vol 147 (1) ◽

pp. 41-46 ◽

Author(s):

Nicole D. Fleming ◽

Robert L. Coleman ◽

Celestine Tung ◽

Shannon N. Westin ◽

Wei Hu ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Phase II trial of oxaliplatin (OXA) combined with paclitaxel (P) as first-line chemotherapy for patients (pts) with advanced ovarian cancer (AOC): Preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.5075 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5075-5075 ◽

Author(s):

G. Deplanque ◽

A. Goupil ◽

M. Fabbro ◽

E. Levy ◽

O. Rixe ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Preliminary Results ◽

Line Chemotherapy

Download Full-text

Experimental Drug Shows Activity Against Advanced Ovarian Cancer in Phase II Trial

Ob Gyn News ◽

10.1016/s0029-7437(07)70576-1 ◽

2007 ◽

Vol 42 (13) ◽

pp. 2

Author(s):

PATRICE WENDLING

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Experimental Drug

Download Full-text

Faculty Opinions recommendation of A randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697918.793457734 ◽

2012 ◽

Author(s):

Hans-Joachim Schmoll

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text